Skip to main content

Judah Frommer

Stock Analyst at Morgan Stanley

Total Price Targets
11
Stocks Covered
9
Sectors
Healthcare
Most Recent
Mar 5, 2026

Notable Calls (Last 12 Months)

Most Bullish

  • RGNX+95.0%
    REGENXBIO Inc.
    $17.00 targetMar 5, 2026
  • EVMN+73.9%
    Evommune, Inc.
    $54.00 targetFeb 18, 2026
  • EVMN+73.8%
    Evommune, Inc.
    $36.00 targetDec 1, 2025

Most Bearish

  • KYMR+29.4%
    Kymera Therapeutics, Inc.
    $123.00 targetFeb 26, 2026
  • TRVI+62.7%
    Trevi Therapeutics, Inc.
    $19.00 targetNov 14, 2025
  • EVMN+73.8%
    Evommune, Inc.
    $36.00 targetDec 1, 2025

Stocks Covered by Judah Frommer

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
RGNXREGENXBIO Inc.$17.00$9.14+86.0%2Mar 5, 2026
KYMRKymera Therapeutics, Inc.$123.00$81.54+50.8%1Feb 26, 2026
EVMNEvommune, Inc.$54.00$24.37+121.6%2Feb 18, 2026
TRVITrevi Therapeutics, Inc.$19.00$13.87+37.0%1Nov 14, 2025
FDMT4D Molecular Therapeutics, Inc.$6.00$9.17-34.6%1Jan 11, 2025
RCUSArcus Biosciences, Inc.$35.00$25.66+36.4%1Oct 8, 2024
BCAXBicara Therapeutics Inc. Common Stock$35.00$21.90+59.8%1Oct 8, 2024
SRPTSarepta Therapeutics, Inc.$95.00$21.60+339.8%1Oct 15, 2021
STOKStoke Therapeutics, Inc.$58.00$33.22+74.6%1Apr 26, 2021

Recent Activity

  • Mar 5, 2026— Set$17.00price target onRGNX(REGENXBIO Inc.)
  • Feb 26, 2026— Set$123.00price target onKYMR(Kymera Therapeutics, Inc.)
  • Feb 18, 2026— Set$54.00price target onEVMN(Evommune, Inc.)
  • Dec 1, 2025— Set$36.00price target onEVMN(Evommune, Inc.)
  • Nov 14, 2025— Set$19.00price target onTRVI(Trevi Therapeutics, Inc.)
  • Jan 11, 2025— Set$6.00price target onFDMT(4D Molecular Therapeutics, Inc.)
  • Nov 15, 2024— Set$22.00price target onRGNX(REGENXBIO Inc.)
  • Oct 8, 2024— Set$35.00price target onRCUS(Arcus Biosciences, Inc.)
  • Oct 8, 2024— Set$35.00price target onBCAX(Bicara Therapeutics Inc. Common Stock)
  • Oct 15, 2021— Set$95.00price target onSRPT(Sarepta Therapeutics, Inc.)
  • Apr 26, 2021— Set$58.00price target onSTOK(Stoke Therapeutics, Inc.)

Frequently Asked Questions

Who is Judah Frommer?

Judah Frommer is a stock analyst at Morgan Stanley covering 9 stocks primarily in Healthcare. They have issued 11 price targets since Apr 26, 2021.

What stocks does Judah Frommer cover?

Judah Frommer currently covers 9 stocks, including RGNX, EVMN, KYMR, TRVI, FDMT.

What is Judah Frommer's latest price target?

Judah Frommer's most recent price target was $17.00 on RGNX (REGENXBIO Inc.), set on Mar 5, 2026.

What is Judah Frommer's highest price target?

Judah Frommer's highest issued price target is $123.00 on KYMR, set on Feb 26, 2026.

Coverage based on publicly published price targets. Not investment advice.